Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy.

Guanglei Fu,Wei Liu,Shanshan Feng,Xiuli Yue
DOI: https://doi.org/10.1039/c2cc36456e
IF: 4.9
2012-01-01
Chemical Communications
Abstract:Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.
What problem does this paper attempt to address?